Cargando…

Effects of tyrosine kinase inhibitor therapy on skin toxicity and skin-related quality of life in patients with lung cancer: An observational study

Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy is the primary treatment option for patients with non-small cell lung cancer (NSCLC). However, one of the major adverse effects associated with this therapy is skin toxicity, which impacts the patient's quality of lif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tseng, Li-Chuan, Chen, Kang-Hua, Wang, Chih-Liang, Weng, Li-Chueh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306373/ https://www.ncbi.nlm.nih.gov/pubmed/32501998 http://dx.doi.org/10.1097/MD.0000000000020510

Ejemplares similares

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of patients with nonsmall cell lung cancer
por: Li, Xi, et al.
Publicado: (2023)

Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor–mutated lung adenocarcinoma
por: Li, Chi-Cheng, et al.
Publicado: (2020)

Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study
por: Ni, Yang, et al.
Publicado: (2016)

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015)

Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinoma
por: Carretero-González, Alberto, et al.
Publicado: (2019)

A protective effect of morning radiotherapy on acute skin toxicity in patients with breast cancer: A prospective cohort study
por: Fuzissaki, Marceila A., et al.
Publicado: (2021)

EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis
por: Yuan, Jin-Qiu, et al.
Publicado: (2017)

Copy number variations of neurotrophic tyrosine receptor kinase 3 (NTRK3) may predict prognosis of ovarian cancer
por: Ge, Li, et al.
Publicado: (2017)

High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments
por: Zhao, Xiayan, et al.
Publicado: (2020)

Construction and validation of a nomogram for patients with skin cancer
por: Ren, Jizhen, et al.
Publicado: (2021)

Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors
por: Huang, Xuan, et al.
Publicado: (2009)

Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report
por: Dong, Min, et al.
Publicado: (2016)

Gastric metastasis and transformation of primary lung adenocarcinoma to small cell cancer after acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors: A case report
por: Liu, Jing, et al.
Publicado: (2021)

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatment: A cohort study
por: Yu, Yuman, et al.
Publicado: (2021)

Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC): A protocol of systematic review and network meta-analysis
por: He, Canfeng, et al.
Publicado: (2021)

Solitary metastasis to the skin and colon from gastric cancer after curative gastrectomy and chemotherapy: A case report
por: Yang, Shuai, et al.
Publicado: (2020)

Thoracic stereotactic body radiation therapy plus first-line tyrosine kinase inhibitors for patients with epidermal growth factor receptor-mutant polymetastatic non-small-cell lung cancer: A propensity-matched retrospective study
por: Wang, Xia, et al.
Publicado: (2021)

Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients
por: Liao, Shian, et al.
Publicado: (2021)

Role of Systemic Antibiotics in Preventing Epidermal Growth Factor Receptor: Tyrosine Kinase Inhibitors-induced Skin Toxicities
por: Dsouza, Philomena Charlotte, et al.
Publicado: (2017)

Modified Tumor Classification With Inclusion of Tumor Characteristics Improves Discrimination and Prediction Accuracy in Oral and Hypopharyngeal Cancer Patients Who Underwent Surgery
por: Lee, Ching-Chih, et al.
Publicado: (2015)

Comparison of xenogeneic acellular dermal matrix and skin grafts in reconstruction of postoperative defects of hypopharyngeal cancer: A retrospective cohort study
por: Zang, Jian, et al.
Publicado: (2020)

The effects of traditional Chinese medicine combined with chemotherapy on immune function and quality of life in patients with non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Zhao, Li-Na, et al.
Publicado: (2020)

Risk of gastrointestinal toxicities with PD-1 inhibitors in cancer patients: A meta-analysis of randomized clinical trials
por: Wei, Wei, et al.
Publicado: (2017)

Mitogen-Activated Protein Kinase Kinase 4 Gene Polymorphism and Cancer Risk
por: Geng, Peiliang, et al.
Publicado: (2015)

The Prognostic Ability of Log Odds of Positive Lymph Nodes in Oral Cavity Squamous Cell Carcinoma
por: Lee, Ching-Chih, et al.
Publicado: (2015)

The effect of enhancing quality of life in patients intervention for advanced lung cancer: Protocol for a randomized clinical study
por: Li, Xianhong, et al.
Publicado: (2020)

Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer
por: Annunziata, Maria Carmela, et al.
Publicado: (2019)

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
por: Szilveszter, Kata P., et al.
Publicado: (2019)

Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon
por: Li, Haowen, et al.
Publicado: (2023)

PD-L1 – inhibitors in neuroendocrine neoplasia: Results from a real-life study
por: Özdirik, Burcin, et al.
Publicado: (2021)

Frequency of fibromyalgia in a cohort of Turkish patients with lung cancer and its effect on pain, sleep quality, fatigue and quality of life
por: Öztürk, Akin, et al.
Publicado: (2023)

Life quality improvement of patients with non-small cell lung cancer undergoing targeted therapy: A case study of continuous care
por: Min, Yonghua, et al.
Publicado: (2023)

Improving functional outcome and quality of life for patients with metastatic lesion of acetabulum undergoing cement augmentation
por: Yan, Taiqiang, et al.
Publicado: (2019)

Health-related quality-of-life assessment in surgical patients with papillary thyroid carcinoma: A single-center analysis from Mainland China
por: Gou, Juxiang, et al.
Publicado: (2017)

LDA-SVM-Based EGFR Mutation Model for NSCLC Brain Metastases: An Observational Study
por: Hu, Nan, et al.
Publicado: (2015)

Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer
por: Prieto-Callejero, Blanca, et al.
Publicado: (2020)

Improvement in High-Grade Osteosarcoma Survival: Results from 202 Patients Treated at a Single Institution in Taiwan
por: Hung, Giun-Yi, et al.
Publicado: (2016)

The association between the composite quality measure “textbook outcome” and long term survival in operated colon cancer
por: Yang, Ching-Chieh, et al.
Publicado: (2020)

Efficacy and toxicity of different concurrent chemoradiotherapy regimens in the treatment of advanced cervical cancer: A network meta-analysis
por: Fu, Zhan-Zhao, et al.
Publicado: (2017)

Determinants for Aggressive End-of-Life Care for Oral Cancer Patients: A Population-Based Study in an Asian Country
por: Chang, Ting-Shou, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1v70ia712eck0m0garr7uc8mb3